WHO report reveals antibiotic use by country
November 14, 2018Research and Development
Britain uses more than twice as many antibiotics as the Netherlands, according to a new report published by the World …
Samsung BioLogics delisted over accounting violations
November 14, 2018Research and Development Business, Samsung, Samsung BioLogics, accounting, south korea
South Korean firm Samsung BioLogics has been delisted from the South Korean stock exchange. The decision has come after the …
Novartis’ Entresto tops enalapril in stabilised heart failure patients
November 13, 2018Manufacturing and Production, Research and Development Entresto, Novartis, cardiovascular, enalapril, heart failure, pharma
Novartis has declared new findings for Entresto (sacubitril/valsartan) at the American Heart Association’s (AHA) scientific sessions, showing that the drug proved …
Gilead appoint Pfizer and AbbVie veteran as VP of governmental affairs
November 13, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
American antiviral drug specialist Gilead have appointed Pfizer and AbbVie veteran Michael Boyd as VP of government affairs and policy …
Cases of measles nearly quadruple since last year in UK
November 13, 2018Manufacturing and Production MMR, Public Health England, UK, health, measles
Public Health England is urging the public to ensure that they have received two doses of the MMR vaccine after …
Azacitidine and nivolumab combo proves successful in phase II trial
November 13, 2018Manufacturing and Production Cancer, leukaemia, opdivo, pharma, texas
A combination of chemotherapy drug azacitidine and nivolumab (Bristol-Myers Squibb’s Opdivo) has proven effective in treating patients with relapsed or …
AstraZeneca sells off paediatric lung infection drug to Sobi for $1.5bn
November 13, 2018Manufacturing and Production, Sales and Marketing AstraZeneca, Synagis, espiratory syncytial virus, pharma, sobi
AstraZeneca has jettisoned another non-essential asset with the sale of Synagis (palivizumab), a preventative treatment for infections relating to respiratory …
Samsung Biologics shares fall by 20% after Korean investigation
November 13, 2018Manufacturing and Production Shares, accounting, pharma, smasung biologics, stockmarket
Shares in Korean firm Samsung BioLogics plummeted this week, falling by as much as 20% on Monday, after the South …
MSD’s Keytruda chalks up FDA approval in liver cancer
November 12, 2018Sales and Marketing Cancer, FDA, US, hepatocellular carcinoma, keytruda, pharma
MSD’s blockbuster immunotherapy Keytruda has secured another FDA approval, this time for the treatment of hepatocellular carcinoma (HCC) in patients …
Working Life: Philippe Bastide, Head of Biosimilars, Mundipharma
November 12, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Cancer, Mundipharma, Philippe Bastide, biosimilars, leukaemia
“Don’t conform to what people want – take risks. The people who make a big difference are the ones who …
FDA commissioner Scott Gottlieb says that more rigorous approval process would be unique to opioids
November 12, 2018Sales and Marketing FDA, Gottlieb, opioid crisis, opioids
Food and Drug Administration (FDA) commissioner Scott Gottlieb has said that if a more rigorous approval process is introduced for …
AZ’s Farxiga shows strength in largest ever SGLT2 inhibitor cardiovascular outcomes study
November 12, 2018Research and Development, Sales and Marketing AstraZeneca, cardiovascular, farxiga, pharma
AstraZeneca has revealed new data for its sodium-glucose co-transporter 2 (SGLT2) inhibitor Farxiga (dapagliflozin) at the American Heart Association (AHA) …
No-deal Brexit preparations are a waste of time and money, according to Welsh industry representatives
November 12, 2018Sales and Marketing ABPI, brexit, no-deal, pharma, stockpiling
The UK government’s request that pharmaceutical companies stockpile an additional six weeks’ worth of medicine, in preparation for a no-deal …
Hundreds die in worst Ebola outbreak in Congo’s history
November 12, 2018Sales and Marketing
Hundreds have died in a recent outbreak of Ebola in the Democratic Republic of Congo (DRC), in what has been …
GSK veteran Dave Tudor joins MMIC in Scotland
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, Scotland, dave tudor, life sciences, manufacturing
GlaxoSmithKline veteran, Dave Tudor, is set to take on the role of Managing Director of the Medicines Manufacturing Innovation Centre …
Eisai’s Lenvima wins over NICE in liver cancer in just three months
November 9, 2018Medical Communications, Sales and Marketing Cancer, Eisai, Lenvima, Levantinib, NHS, NICE, UK, liver cancer, pharma
Eisai has revealed that its multireceptor Tyrosine Kinase Inhibitor Lenvima (lenvatinib) has been recommended by NICE, meaning it can now …
Top Ten most popular articles on Pharmafile.com this week!
November 9, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AstraZeneca, Celgene, GSK, Novo Nordisk, politics, popular, top 10, vaccines
The biggest news this week came from Israeli biotech Zion Medical after it was announced that HIV drug Gammora was …
NICE fail to recommend AstraZeneca’s cancer drug Olaparib on cost effectiveness basis
November 9, 2018Medical Communications, Sales and Marketing AstraZeneca, NHS, NICE, UK, olaparib, pharma
Britain’s cost effectiveness body the National Institute of Health and Care Excellence (NICE) has chosen not to recommend AstraZeneca’s Olaparib …
NHS diabetes prescriptions top £1 billion a year
November 9, 2018Medical Communications, Sales and Marketing Health Education England, NHS, UK, diabetes, pharma
The NHS in England is now spending over £1billion a year on diabetes prescriptions, almost doubling in the last decade, …
Alabama’s biggest insurer will no longer cover OxyContin prescriptions
November 9, 2018Medical Communications Alabama, Blue Cross and Blue Shield, OxyContin, insurance, opioids
The state of Alabama’s biggest insurer Blue Cross and Blue Shield will no long cover opioid painkiller OxyContin. The decision …
Latest content
Scots neonatal innovations target hearing loss and earlier care
Agentis Health Group acquires Clinical Pharmacist Solutions
